Target
$16.12 → $16
Current stock research snapshot · 8/6/26 20 days old
CERTCertara Inc.
Investment conviction●●○○○2 of 5 · current snapshot
Research target$16Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 8/6/26
Market cap$1.17BSnapshot value · 8/6/26
Research history
See all CERT changes ↗What changed
Biosimulation software and services for clinical trial design optimization — digital infrastructure picks-and-shovels for pharma R&D. $355M rev, $1.7B cap.
NVIDIA BioNeMo Agent Toolkit integration announced Jul 2026 (AI-driven biosimulation automation); Q2 2026 earnings early Aug (services stabilization, AI monetization progress); Bio Venture Catalyst program launch at BIO 2026 for emerging biotechs; Certara IQ QSP platform expansion
needs primary source validation
needs primary source validation
Snapshot · 8/6/26🟡 Mixed · 13F 16+/7-×0.5 · short↑0.28
Snapshot · 8/6/26